Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 271

The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.

The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project BETA psychopharmacology workgroup

Open access
Hays, Hannah, Jolliff, Heath, Casavant, Marcel·2012·Western Journal of Emergency Medicine

Abstract

To the Editor: We were excited to read the article by Michael Wilson et al1 in the March 2012 issue of the Western Journal of Emergency Medicine regarding pharmacologic strategies for the management of agitated patients in the emergency setting. This article highlights several important points including the optimal management of stimulant-induced agitation and the feasibility of and reasons for differentiating acute alcohol intoxication from withdrawal, as optimal pharmacologic interventions for each might vary. While the authors correctly highlight the importance of preferential use of benzodiazepines to calm patients intoxicated with most recreational drugs, we believe that the use of benzodiazepines as first line treatment for agitation should be extended to include that from acute overdose of other agents. Because many common medications taken in acute overdose, such as cyclic antidepressants, SSRIs, diphenhydramine and other over-the-counter medications have toxicity profiles that include anticholinergic, proconvulsant, hyperthermic, and cardiotoxic (QTc prolongation) properties, which overlap with antipsychotics, we recommend benzodiazepines as first, second and third line for agitation in these instances to avoid contributing to these potentially life threatening adverse effects. Further, benzodiazepines raise the seizure threshold and promote conditions that precipitate heat dissipation.2,3 If, after liberal use of benzodiazepines, the patient still displays agitation necessitating further pharmacologic intervention, we then use antipsychotics with caution. We found the reported maximum daily dose of lorazepam in the Table1 to be dangerously low. We were glad to see the emphasis on patient and staff safety, given the increasing awareness of the excited delirium syndrome, thought to be due to a multifactorial interaction of delirium and agitation often secondary to stimulant intoxication, leading to hyperthermia, profound acidemia and sometimes death.4-7 We regret that the authors left out a discussion of the increasing use of the dissociative agent ketamine for rapid control of dangerous behavior in this subset of patients. Although no controlled trials exist regarding its use in agitated patients, several case reports show rapid, satisfactory results without significant respiratory and cardiovascular adverse effects.5,8 Potential adverse effects of ketamine, although uncommon, include hypertension, emergence phenomena, increased oral secretions and laryngospasm.7,10 Hannah Hays, MD* Heath A. Jolliff, DO, FACEP, FAAEM * Marcel J. Casavant, MD, FACEP, FACMT †

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.5811/westjem.2012.7.12527

Cites

46 of 46 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 46 references

Cited by

See all 271

Metadata

Authors
Hays, H., Jolliff, H., & Casavant, M.
Venue
Western Journal of Emergency Medicine
Published
2012-12-01
Volume
13
Issue
6
Pages
536-537
ISSN
  • 1936-900X (ISSN-L)
  • 1936-9018
OpenAlex
W2130649501
Cited by
271
References
46
FWCI
20.85
Type
journal article
Language
en
Open access
gold

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project BETA psychopharmacology workgroup. https://app.cochat.ai/papers/10.5811/westjem.2012.7.12527
The paper
Hays, H., Jolliff, H., & Casavant, M. (2012). The psychopharmacology of agitation: consensus statement of the American association for emergency psychiatry project BETA psychopharmacology workgroup. Western Journal of Emergency Medicine. https://doi.org/10.5811/westjem.2012.7.12527

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.